AVEO Oncology ^Investors

AVEO Oncology is a venture capital fund based in Cambridge, Massachusetts, established in 2001 The firm specializes in the development and commercialization of innovative cancer therapies With an investment scale of approximately $81 million, AVEO Oncology focuses on advancing its portfolio through strategic partnerships and collaborations The company is committed to improving patient outcomes by leveraging cutting-edge research and technology in oncology